| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.27e-07 | 188 | 26 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.47e-07 | 749 | 26 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 9.92e-06 | 398 | 26 | 6 | GO:0046982 | |
| GeneOntologyMolecularFunction | ErbB-3 class receptor binding | 2.44e-05 | 6 | 26 | 2 | GO:0043125 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 8.11e-05 | 65 | 26 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.80e-05 | 599 | 26 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.07e-04 | 12 | 26 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.47e-04 | 14 | 26 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.80e-04 | 85 | 26 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 6.82e-04 | 1205 | 26 | 7 | GO:0046983 | |
| GeneOntologyMolecularFunction | structural molecule activity | 8.29e-04 | 891 | 26 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 8.63e-04 | 145 | 26 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.07e-03 | 156 | 26 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 3.60e-03 | 815 | 26 | 5 | GO:0042803 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.42e-08 | 63 | 26 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | Schwann cell differentiation | 6.47e-07 | 55 | 26 | 4 | GO:0014037 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 3.89e-06 | 1077 | 26 | 9 | GO:0098609 | |
| GeneOntologyBiologicalProcess | peripheral nervous system development | 6.61e-06 | 98 | 26 | 4 | GO:0007422 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 9.15e-06 | 4 | 26 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | Schwann cell development | 2.78e-05 | 47 | 26 | 3 | GO:0014044 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 3.20e-05 | 7 | 26 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 3.95e-05 | 313 | 26 | 5 | GO:0098742 | |
| GeneOntologyBiologicalProcess | glial cell development | 4.24e-05 | 157 | 26 | 4 | GO:0021782 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 4.26e-05 | 8 | 26 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 4.45e-05 | 321 | 26 | 5 | GO:0010001 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 8.35e-05 | 11 | 26 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 8.35e-05 | 11 | 26 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 1.12e-04 | 927 | 26 | 7 | GO:0030155 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 1.18e-04 | 13 | 26 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 1.18e-04 | 13 | 26 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 1.18e-04 | 13 | 26 | 2 | GO:0038133 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.33e-04 | 405 | 26 | 5 | GO:0033674 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.38e-04 | 14 | 26 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 1.38e-04 | 14 | 26 | 2 | GO:0038129 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 1.58e-04 | 84 | 26 | 3 | GO:1903053 | |
| GeneOntologyBiologicalProcess | gliogenesis | 1.86e-04 | 435 | 26 | 5 | GO:0042063 | |
| GeneOntologyBiologicalProcess | metanephros development | 2.28e-04 | 95 | 26 | 3 | GO:0001656 | |
| GeneOntologyBiologicalProcess | heart development | 2.94e-04 | 757 | 26 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 3.23e-04 | 490 | 26 | 5 | GO:0051347 | |
| GeneOntologyBiologicalProcess | striated muscle cell proliferation | 3.51e-04 | 110 | 26 | 3 | GO:0014855 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 3.80e-04 | 23 | 26 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | metanephric nephron epithelium development | 3.80e-04 | 23 | 26 | 2 | GO:0072243 | |
| GeneOntologyBiologicalProcess | axon guidance | 4.20e-04 | 285 | 26 | 4 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.25e-04 | 286 | 26 | 4 | GO:0097485 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 5.26e-04 | 27 | 26 | 2 | GO:0038128 | |
| GeneOntologyBiologicalProcess | metanephric epithelium development | 5.66e-04 | 28 | 26 | 2 | GO:0072207 | |
| GeneOntologyBiologicalProcess | positive regulation of filopodium assembly | 9.38e-04 | 36 | 26 | 2 | GO:0051491 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.19e-03 | 377 | 26 | 4 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.21e-03 | 378 | 26 | 4 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.22e-03 | 379 | 26 | 4 | GO:0045229 | |
| GeneOntologyBiologicalProcess | response to wounding | 1.23e-03 | 659 | 26 | 5 | GO:0009611 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.28e-03 | 42 | 26 | 2 | GO:0099560 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 1.28e-03 | 42 | 26 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 1.34e-03 | 43 | 26 | 2 | GO:0071711 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.47e-03 | 685 | 26 | 5 | GO:0050808 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 1.48e-03 | 686 | 26 | 5 | GO:0043549 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.66e-03 | 48 | 26 | 2 | GO:0043277 | |
| GeneOntologyBiologicalProcess | neuron development | 1.77e-03 | 1463 | 26 | 7 | GO:0048666 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 1.95e-03 | 199 | 26 | 3 | GO:0051147 | |
| GeneOntologyBiologicalProcess | myelination | 2.15e-03 | 206 | 26 | 3 | GO:0042552 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 2.25e-03 | 209 | 26 | 3 | GO:0007272 | |
| GeneOntologyBiologicalProcess | axon ensheathment | 2.25e-03 | 209 | 26 | 3 | GO:0008366 | |
| GeneOntologyBiologicalProcess | regulation of filopodium assembly | 2.34e-03 | 57 | 26 | 2 | GO:0051489 | |
| GeneOntologyBiologicalProcess | regulation of muscle tissue development | 2.34e-03 | 57 | 26 | 2 | GO:1901861 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.50e-03 | 59 | 26 | 2 | GO:0085029 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 2.59e-03 | 780 | 26 | 5 | GO:0042327 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 3.04e-03 | 1186 | 26 | 6 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 3.05e-03 | 810 | 26 | 5 | GO:0051338 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.41e-08 | 656 | 26 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.56e-08 | 658 | 26 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | microfibril | 4.84e-07 | 13 | 26 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | ERBB3:ERBB2 complex | 1.49e-06 | 2 | 26 | 2 | GO:0038143 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.80e-06 | 530 | 26 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.00e-04 | 17 | 26 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | neuromuscular junction | 3.56e-04 | 112 | 26 | 3 | GO:0031594 | |
| GeneOntologyCellularComponent | basement membrane | 4.57e-04 | 122 | 26 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.71e-04 | 583 | 26 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | phagocytic cup | 6.77e-04 | 31 | 26 | 2 | GO:0001891 | |
| GeneOntologyCellularComponent | synaptic cleft | 7.67e-04 | 33 | 26 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.48e-03 | 405 | 26 | 4 | GO:0045211 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.44e-03 | 59 | 26 | 2 | GO:0098636 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 6.06e-03 | 94 | 26 | 2 | GO:0032580 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 7.12e-03 | 320 | 26 | 3 | GO:0016323 | |
| GeneOntologyCellularComponent | postsynapse | 7.59e-03 | 1018 | 26 | 5 | GO:0098794 | |
| GeneOntologyCellularComponent | basal plasma membrane | 9.38e-03 | 354 | 26 | 3 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 1.12e-02 | 378 | 26 | 3 | GO:0045178 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.22e-02 | 135 | 26 | 2 | GO:0031985 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 8.09e-06 | 2 | 15 | 2 | HP:0005900 | |
| HumanPheno | Abnormal upper to lower segment ratio | 2.42e-05 | 3 | 15 | 2 | HP:0012772 | |
| MousePheno | abnormal Schwann cell precursor morphology | 9.20e-06 | 3 | 25 | 2 | MP:0004074 | |
| MousePheno | decreased Schwann cell precursor number | 9.20e-06 | 3 | 25 | 2 | MP:0004075 | |
| MousePheno | abnormal Schwann cell morphology | 3.77e-05 | 37 | 25 | 3 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 3.77e-05 | 37 | 25 | 3 | MP:0001105 | |
| MousePheno | abnormal sensory neuron morphology | 1.49e-04 | 473 | 25 | 6 | MP:0000965 | |
| MousePheno | abnormal somatic sensory system morphology | 1.70e-04 | 702 | 25 | 7 | MP:0000959 | |
| MousePheno | decreased respiration | 2.19e-04 | 170 | 25 | 4 | MP:0014274 | |
| MousePheno | atrioventricular valve regurgitation | 2.37e-04 | 13 | 25 | 2 | MP:0006046 | |
| MousePheno | abnormal petrosal ganglion morphology | 2.76e-04 | 14 | 25 | 2 | MP:0001084 | |
| MousePheno | abnormal somatic nervous system morphology | 2.85e-04 | 1025 | 25 | 8 | MP:0002752 | |
| MousePheno | abnormal glial cell morphology | 3.15e-04 | 345 | 25 | 5 | MP:0003634 | |
| MousePheno | hindlimb paralysis | 3.65e-04 | 79 | 25 | 3 | MP:0000755 | |
| MousePheno | abnormal neuroendocrine cell morphology | 4.11e-04 | 17 | 25 | 2 | MP:0010913 | |
| MousePheno | limb paralysis | 4.22e-04 | 83 | 25 | 3 | MP:0013147 | |
| MousePheno | decreased atrioventricular cushion size | 4.62e-04 | 18 | 25 | 2 | MP:0000301 | |
| MousePheno | poor circulation | 5.15e-04 | 19 | 25 | 2 | MP:0001633 | |
| MousePheno | abnormal ventral spinal root morphology | 5.15e-04 | 19 | 25 | 2 | MP:0003993 | |
| MousePheno | abnormal sensory neuron innervation pattern | 5.71e-04 | 92 | 25 | 3 | MP:0000968 | |
| Domain | EGF_1 | TENM1 LAMA2 UMOD LAMB2 LTBP3 FBN1 FBN2 TENM4 MEGF6 EGFL8 TENM3 TIE1 NAGPA SSPOP TENM2 FBN3 MEGF10 PEAR1 | 2.10e-28 | 255 | 26 | 18 | PS00022 |
| Domain | EGF_2 | TENM1 LAMA2 UMOD LAMB2 LTBP3 FBN1 FBN2 TENM4 MEGF6 EGFL8 TENM3 TIE1 NAGPA SSPOP TENM2 FBN3 MEGF10 PEAR1 | 4.28e-28 | 265 | 26 | 18 | PS01186 |
| Domain | EGF | TENM1 LAMA2 UMOD LAMB2 LTBP3 FBN1 FBN2 TENM4 MEGF6 EGFL8 TENM3 TIE1 NAGPA TENM2 FBN3 MEGF10 PEAR1 | 7.82e-27 | 235 | 26 | 17 | SM00181 |
| Domain | EGF-like_dom | TENM1 LAMA2 UMOD LAMB2 LTBP3 FBN1 FBN2 TENM4 MEGF6 EGFL8 TENM3 TIE1 NAGPA TENM2 FBN3 MEGF10 PEAR1 | 2.15e-26 | 249 | 26 | 17 | IPR000742 |
| Domain | EGF-like_CS | TENM1 LAMA2 UMOD LAMB2 LTBP3 FBN1 FBN2 TENM4 MEGF6 EGFL8 TENM3 TIE1 NAGPA TENM2 FBN3 MEGF10 PEAR1 | 4.88e-26 | 261 | 26 | 17 | IPR013032 |
| Domain | EGF_3 | TENM1 UMOD LTBP3 FBN1 FBN2 TENM4 MEGF6 EGFL8 TENM3 TIE1 NAGPA SSPOP TENM2 FBN3 MEGF10 PEAR1 | 1.12e-24 | 235 | 26 | 16 | PS50026 |
| Domain | Growth_fac_rcpt_ | 5.85e-15 | 156 | 26 | 10 | IPR009030 | |
| Domain | EGF_extracell | 1.54e-12 | 60 | 26 | 7 | IPR013111 | |
| Domain | EGF_2 | 1.54e-12 | 60 | 26 | 7 | PF07974 | |
| Domain | Tox-GHH_dom | 2.95e-12 | 4 | 26 | 4 | IPR028916 | |
| Domain | TENEURIN_N | 2.95e-12 | 4 | 26 | 4 | PS51361 | |
| Domain | Ten_N | 2.95e-12 | 4 | 26 | 4 | IPR009471 | |
| Domain | Tox-GHH | 2.95e-12 | 4 | 26 | 4 | PF15636 | |
| Domain | Ten_N | 2.95e-12 | 4 | 26 | 4 | PF06484 | |
| Domain | EGF_CA | 3.72e-12 | 122 | 26 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.25e-12 | 124 | 26 | 8 | IPR001881 | |
| Domain | YD | 1.47e-11 | 5 | 26 | 4 | IPR006530 | |
| Domain | EGF_CA | 2.10e-11 | 86 | 26 | 7 | PF07645 | |
| Domain | EMI | 2.13e-11 | 17 | 26 | 5 | PS51041 | |
| Domain | EGF_Ca-bd_CS | 4.96e-11 | 97 | 26 | 7 | IPR018097 | |
| Domain | EGF_CA | 5.74e-11 | 99 | 26 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.17e-11 | 100 | 26 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.34e-11 | 106 | 26 | 7 | IPR000152 | |
| Domain | TB | 1.03e-10 | 7 | 26 | 4 | PF00683 | |
| Domain | - | 2.06e-10 | 8 | 26 | 4 | 3.90.290.10 | |
| Domain | hEGF | 3.34e-10 | 28 | 26 | 5 | PF12661 | |
| Domain | TB | 3.70e-10 | 9 | 26 | 4 | PS51364 | |
| Domain | TB_dom | 3.70e-10 | 9 | 26 | 4 | IPR017878 | |
| Domain | Laminin_EGF | 1.10e-09 | 35 | 26 | 5 | PF00053 | |
| Domain | EGF_Lam | 1.10e-09 | 35 | 26 | 5 | SM00180 | |
| Domain | Laminin_EGF | 1.69e-09 | 38 | 26 | 5 | IPR002049 | |
| Domain | NHL | 2.09e-09 | 13 | 26 | 4 | PS51125 | |
| Domain | Rhs_assc_core | 2.39e-09 | 3 | 26 | 3 | IPR022385 | |
| Domain | FBN | 2.39e-09 | 3 | 26 | 3 | IPR011398 | |
| Domain | EMI_domain | 5.31e-09 | 16 | 26 | 4 | IPR011489 | |
| Domain | EGF | 1.72e-08 | 126 | 26 | 6 | PF00008 | |
| Domain | cEGF | 4.32e-08 | 26 | 26 | 4 | IPR026823 | |
| Domain | cEGF | 4.32e-08 | 26 | 26 | 4 | PF12662 | |
| Domain | - | 2.35e-07 | 39 | 26 | 4 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.63e-07 | 46 | 26 | 4 | IPR011042 | |
| Domain | CarboxyPept-like_regulatory | 1.61e-06 | 17 | 26 | 3 | IPR008969 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 1.12e-05 | 4 | 26 | 2 | IPR016245 | |
| Domain | GF_recep_IV | 2.79e-05 | 6 | 26 | 2 | PF14843 | |
| Domain | GF_recep_IV | 2.79e-05 | 6 | 26 | 2 | IPR032778 | |
| Domain | Furin-like | 3.90e-05 | 7 | 26 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 3.90e-05 | 7 | 26 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 3.90e-05 | 7 | 26 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 3.90e-05 | 7 | 26 | 2 | PF01030 | |
| Domain | - | 3.90e-05 | 7 | 26 | 2 | 3.80.20.20 | |
| Domain | LAMININ_NTER | 2.21e-04 | 16 | 26 | 2 | PS51117 | |
| Domain | Laminin_N | 2.21e-04 | 16 | 26 | 2 | PF00055 | |
| Domain | Laminin_N | 2.21e-04 | 16 | 26 | 2 | IPR008211 | |
| Domain | LamNT | 2.21e-04 | 16 | 26 | 2 | SM00136 | |
| Domain | TyrKc | 2.43e-04 | 88 | 26 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.43e-04 | 88 | 26 | 3 | IPR020635 | |
| Domain | Furin_repeat | 2.81e-04 | 18 | 26 | 2 | IPR006212 | |
| Domain | FU | 2.81e-04 | 18 | 26 | 2 | SM00261 | |
| Domain | Galactose-bd-like | 2.95e-04 | 94 | 26 | 3 | IPR008979 | |
| Domain | PROTEIN_KINASE_TYR | 3.24e-04 | 97 | 26 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.24e-04 | 97 | 26 | 3 | IPR008266 | |
| Domain | Pkinase_Tyr | 7.45e-04 | 129 | 26 | 3 | PF07714 | |
| Domain | EGF_LAM_2 | 7.91e-04 | 30 | 26 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 7.91e-04 | 30 | 26 | 2 | PS01248 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.06e-04 | 138 | 26 | 3 | IPR001245 | |
| Domain | TSP_1 | 3.45e-03 | 63 | 26 | 2 | PF00090 | |
| Domain | TSP1 | 3.67e-03 | 65 | 26 | 2 | SM00209 | |
| Domain | TSP1_rpt | 3.67e-03 | 65 | 26 | 2 | IPR000884 | |
| Domain | TSP1 | 3.67e-03 | 65 | 26 | 2 | PS50092 | |
| Domain | - | 4.61e-03 | 73 | 26 | 2 | 2.60.120.260 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.99e-08 | 300 | 17 | 7 | M610 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.33e-08 | 37 | 17 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.91e-07 | 44 | 17 | 4 | M26969 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 2.29e-07 | 46 | 17 | 4 | M239 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.30e-06 | 25 | 17 | 3 | M39713 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.07e-06 | 32 | 17 | 3 | MM14854 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.02e-05 | 258 | 17 | 5 | MM14572 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.30e-05 | 39 | 17 | 3 | MM14601 | |
| Pathway | REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING | 1.37e-05 | 5 | 17 | 2 | M26937 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 3.82e-05 | 8 | 17 | 2 | M47850 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 6.36e-05 | 66 | 17 | 3 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 6.36e-05 | 66 | 17 | 3 | M18 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 7.48e-05 | 11 | 17 | 2 | MM15478 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 7.48e-05 | 11 | 17 | 2 | M158 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 8.97e-05 | 12 | 17 | 2 | MM14550 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 1.06e-04 | 13 | 17 | 2 | M549 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.06e-04 | 13 | 17 | 2 | MM15320 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.06e-04 | 13 | 17 | 2 | M27729 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.24e-04 | 14 | 17 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 1.24e-04 | 14 | 17 | 2 | MM14531 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 1.42e-04 | 15 | 17 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.42e-04 | 15 | 17 | 2 | M27608 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.63e-04 | 16 | 17 | 2 | M570 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 3.12e-04 | 22 | 17 | 2 | M26929 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 3.41e-04 | 23 | 17 | 2 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 3.41e-04 | 23 | 17 | 2 | M18719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 4.04e-04 | 25 | 17 | 2 | M47934 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 4.37e-04 | 26 | 17 | 2 | M29535 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 4.37e-04 | 26 | 17 | 2 | MM15501 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 5.20e-04 | 325 | 17 | 4 | M12868 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 5.45e-04 | 29 | 17 | 2 | M27756 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.84e-04 | 30 | 17 | 2 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.84e-04 | 30 | 17 | 2 | M27216 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.89e-04 | 140 | 17 | 3 | M587 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 7.07e-04 | 33 | 17 | 2 | M39455 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 7.07e-04 | 33 | 17 | 2 | M39503 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 9.38e-04 | 38 | 17 | 2 | MM14874 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.88e-04 | 39 | 17 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.88e-04 | 39 | 17 | 2 | MM15165 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.09e-03 | 41 | 17 | 2 | M27778 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 1.26e-03 | 44 | 17 | 2 | M175 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.26e-03 | 44 | 17 | 2 | MM14520 | |
| Pathway | WP_FOCAL_ADHESION | 1.36e-03 | 187 | 17 | 3 | MM15913 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 1.37e-03 | 46 | 17 | 2 | MM15950 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.43e-03 | 47 | 17 | 2 | M646 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 1.49e-03 | 48 | 17 | 2 | M219 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 1.49e-03 | 48 | 17 | 2 | MM15479 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.62e-03 | 50 | 17 | 2 | M553 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.63e-03 | 199 | 17 | 3 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 1.63e-03 | 199 | 17 | 3 | M39402 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 1.89e-03 | 54 | 17 | 2 | M29742 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 1.96e-03 | 55 | 17 | 2 | M47952 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.25e-03 | 59 | 17 | 2 | M27218 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 2.25e-03 | 59 | 17 | 2 | M39886 | |
| Pathway | WP_CANCER_PATHWAYS | 2.71e-03 | 507 | 17 | 4 | M48302 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 2.98e-03 | 68 | 17 | 2 | M39456 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.98e-03 | 68 | 17 | 2 | M27303 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.22e-03 | 532 | 17 | 4 | M27870 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.70e-03 | 76 | 17 | 2 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.80e-03 | 77 | 17 | 2 | MM14670 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.99e-03 | 79 | 17 | 2 | M27643 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 4.40e-03 | 83 | 17 | 2 | M27163 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 4.40e-03 | 83 | 17 | 2 | M47961 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 4.40e-03 | 83 | 17 | 2 | M39637 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 4.50e-03 | 84 | 17 | 2 | M3228 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 4.50e-03 | 84 | 17 | 2 | M39839 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.50e-03 | 84 | 17 | 2 | M7098 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 4.82e-03 | 87 | 17 | 2 | M12467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 5.04e-03 | 89 | 17 | 2 | M47963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 5.38e-03 | 92 | 17 | 2 | M47927 | |
| Pathway | WP_ERBB_SIGNALING | 5.38e-03 | 92 | 17 | 2 | M39715 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.61e-03 | 94 | 17 | 2 | M1041 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.84e-03 | 96 | 17 | 2 | M39834 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 6.32e-03 | 100 | 17 | 2 | MM15826 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.47e-03 | 109 | 17 | 2 | MM15164 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 7.60e-03 | 110 | 17 | 2 | M27162 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.74e-03 | 111 | 17 | 2 | M27416 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 8.01e-03 | 113 | 17 | 2 | MM14783 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.14e-03 | 114 | 17 | 2 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 8.70e-03 | 118 | 17 | 2 | MM15588 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 8.70e-03 | 118 | 17 | 2 | M713 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 8.99e-03 | 120 | 17 | 2 | MM14982 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 9.57e-03 | 124 | 17 | 2 | M27285 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.26e-02 | 143 | 17 | 2 | M27275 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.29e-02 | 418 | 17 | 3 | MM15587 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.58e-02 | 161 | 17 | 2 | M27871 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 2.88e-13 | 4 | 27 | 4 | 10225957 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 2.88e-13 | 4 | 27 | 4 | 12000766 | |
| Pubmed | 1.01e-11 | 7 | 27 | 4 | 12915301 | ||
| Pubmed | 1.67e-11 | 71 | 27 | 6 | 33541421 | ||
| Pubmed | 2.01e-11 | 8 | 27 | 4 | 10331952 | ||
| Pubmed | 6.03e-11 | 10 | 27 | 4 | 38713721 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.67e-09 | 4 | 27 | 3 | 25034023 | |
| Pubmed | 4.04e-09 | 175 | 27 | 6 | 28071719 | ||
| Pubmed | 1.46e-08 | 7 | 27 | 3 | 10625539 | ||
| Pubmed | The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration. | 3.49e-08 | 9 | 27 | 3 | 19295126 | |
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 12122015 | ||
| Pubmed | 7.02e-08 | 51 | 27 | 4 | 16919471 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12399449 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20581867 | ||
| Pubmed | Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers. | 5.80e-07 | 2 | 27 | 2 | 35108525 | |
| Pubmed | Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer. | 5.80e-07 | 2 | 27 | 2 | 17203234 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21851253 | ||
| Pubmed | Correlation of Gli1 and HER2 expression in gastric cancer: Identification of novel target. | 5.80e-07 | 2 | 27 | 2 | 29321573 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22733765 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12429739 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 5.80e-07 | 2 | 27 | 2 | 30044367 | |
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 5.80e-07 | 2 | 27 | 2 | 26494287 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 5.80e-07 | 2 | 27 | 2 | 21440062 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16199884 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15131124 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30068375 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25739551 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 38441358 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 10205169 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 5.80e-07 | 2 | 27 | 2 | 12524050 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21638049 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 5.80e-07 | 2 | 27 | 2 | 20404337 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17638894 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27317872 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12853564 | ||
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 5.80e-07 | 2 | 27 | 2 | 29625025 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29511113 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21709195 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 5.80e-07 | 2 | 27 | 2 | 8791520 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12134143 | ||
| Pubmed | Higher-order association states of cellular ERBB3 probed with photo-cross-linkable aptamers. | 5.80e-07 | 2 | 27 | 2 | 18942860 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35484136 | ||
| Pubmed | The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers. | 5.80e-07 | 2 | 27 | 2 | 33907275 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22848366 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 8120105 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35419902 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 18056992 | ||
| Pubmed | HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer. | 5.80e-07 | 2 | 27 | 2 | 25915155 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 5.80e-07 | 2 | 27 | 2 | 8307578 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 5.80e-07 | 2 | 27 | 2 | 10504303 | |
| Pubmed | Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. | 5.80e-07 | 2 | 27 | 2 | 25017122 | |
| Pubmed | Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3. | 5.80e-07 | 2 | 27 | 2 | 23698633 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 35177646 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15221638 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 5.80e-07 | 2 | 27 | 2 | 7744963 | |
| Pubmed | Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. | 5.80e-07 | 2 | 27 | 2 | 7538656 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25326665 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26208475 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 5.80e-07 | 2 | 27 | 2 | 18006876 | |
| Pubmed | Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung Cancer. | 5.80e-07 | 2 | 27 | 2 | 29959202 | |
| Pubmed | HER2 expression as a potential marker for response to therapy targeted to the EGFR. | 5.80e-07 | 2 | 27 | 2 | 16622439 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 5.80e-07 | 2 | 27 | 2 | 24833718 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22157714 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31932682 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20589763 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 10799311 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22806884 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23680147 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23843458 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26526577 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 34171264 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24265020 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20529844 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23688700 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22983903 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27358485 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 5.80e-07 | 2 | 27 | 2 | 25524144 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21385943 | ||
| Pubmed | CRISPR-assisted receptor deletion reveals distinct roles for ERBB2 and ERBB3 in skin keratinocytes. | 5.80e-07 | 2 | 27 | 2 | 28805349 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23133647 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12000754 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30306291 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22248472 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12483526 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12888923 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 5.80e-07 | 2 | 27 | 2 | 16407178 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25112701 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 14737100 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 5.80e-07 | 2 | 27 | 2 | 1852206 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15731393 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16307437 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 10359653 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16168116 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26261492 | ||
| Pubmed | Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy. | 5.80e-07 | 2 | 27 | 2 | 29654069 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29338072 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24678002 | ||
| Pubmed | HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors. | 5.80e-07 | 2 | 27 | 2 | 19622585 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26138066 | ||
| Interaction | ZDHHC15 interactions | 1.05e-08 | 125 | 26 | 6 | int:ZDHHC15 | |
| Interaction | FBN1 interactions | 3.81e-05 | 51 | 26 | 3 | int:FBN1 | |
| Interaction | MFAP5 interactions | 4.04e-05 | 52 | 26 | 3 | int:MFAP5 | |
| Interaction | MUC4 interactions | 5.73e-05 | 9 | 26 | 2 | int:MUC4 | |
| Interaction | MFAP2 interactions | 1.05e-04 | 12 | 26 | 2 | int:MFAP2 | |
| Interaction | MBD1 interactions | 1.31e-04 | 77 | 26 | 3 | int:MBD1 | |
| Interaction | SMIM20 interactions | 1.44e-04 | 14 | 26 | 2 | int:SMIM20 | |
| Interaction | PIK3R2 interactions | 2.03e-04 | 230 | 26 | 4 | int:PIK3R2 | |
| Interaction | TMEM134 interactions | 2.15e-04 | 17 | 26 | 2 | int:TMEM134 | |
| Interaction | ZAP70 interactions | 2.22e-04 | 92 | 26 | 3 | int:ZAP70 | |
| Interaction | LTBP1 interactions | 2.22e-04 | 92 | 26 | 3 | int:LTBP1 | |
| Interaction | SHD interactions | 2.42e-04 | 18 | 26 | 2 | int:SHD | |
| Interaction | SYK interactions | 2.83e-04 | 251 | 26 | 4 | int:SYK | |
| Interaction | SHC4 interactions | 3.64e-04 | 22 | 26 | 2 | int:SHC4 | |
| Interaction | ATXN7 interactions | 3.65e-04 | 109 | 26 | 3 | int:ATXN7 | |
| Interaction | LAMA2 interactions | 3.98e-04 | 23 | 26 | 2 | int:LAMA2 | |
| Interaction | SOCS5 interactions | 4.34e-04 | 24 | 26 | 2 | int:SOCS5 | |
| Interaction | DUSP18 interactions | 4.34e-04 | 24 | 26 | 2 | int:DUSP18 | |
| Interaction | NTN5 interactions | 4.34e-04 | 24 | 26 | 2 | int:NTN5 | |
| Interaction | SLA2 interactions | 4.34e-04 | 24 | 26 | 2 | int:SLA2 | |
| Interaction | PRG2 interactions | 4.58e-04 | 285 | 26 | 4 | int:PRG2 | |
| Interaction | SH2B3 interactions | 4.71e-04 | 25 | 26 | 2 | int:SH2B3 | |
| Interaction | HSH2D interactions | 4.71e-04 | 25 | 26 | 2 | int:HSH2D | |
| Interaction | MET interactions | 4.89e-04 | 290 | 26 | 4 | int:MET | |
| Interaction | ZNF532 interactions | 5.51e-04 | 27 | 26 | 2 | int:ZNF532 | |
| Interaction | STAP1 interactions | 5.51e-04 | 27 | 26 | 2 | int:STAP1 | |
| Interaction | TENM4 interactions | 5.93e-04 | 28 | 26 | 2 | int:TENM4 | |
| Interaction | TENM1 interactions | 5.93e-04 | 28 | 26 | 2 | int:TENM1 | |
| Interaction | SLA interactions | 6.36e-04 | 29 | 26 | 2 | int:SLA | |
| Interaction | ELN interactions | 6.36e-04 | 29 | 26 | 2 | int:ELN | |
| Interaction | EGF interactions | 7.27e-04 | 31 | 26 | 2 | int:EGF | |
| Interaction | SH2B1 interactions | 7.75e-04 | 32 | 26 | 2 | int:SH2B1 | |
| Interaction | TVP23B interactions | 7.75e-04 | 32 | 26 | 2 | int:TVP23B | |
| Interaction | SH2D1B interactions | 7.75e-04 | 32 | 26 | 2 | int:SH2D1B | |
| Interaction | HOXA1 interactions | 1.05e-03 | 356 | 26 | 4 | int:HOXA1 | |
| Interaction | CNTNAP2 interactions | 1.08e-03 | 158 | 26 | 3 | int:CNTNAP2 | |
| Interaction | PLA2G2A interactions | 1.09e-03 | 38 | 26 | 2 | int:PLA2G2A | |
| Interaction | ADGRE5 interactions | 1.18e-03 | 163 | 26 | 3 | int:ADGRE5 | |
| Interaction | ODF2L interactions | 1.21e-03 | 40 | 26 | 2 | int:ODF2L | |
| Interaction | TNS1 interactions | 1.27e-03 | 41 | 26 | 2 | int:TNS1 | |
| Interaction | MATK interactions | 1.40e-03 | 43 | 26 | 2 | int:MATK | |
| Interaction | SHC2 interactions | 1.46e-03 | 44 | 26 | 2 | int:SHC2 | |
| Interaction | SH2D1A interactions | 1.53e-03 | 45 | 26 | 2 | int:SH2D1A | |
| Interaction | TMEM230 interactions | 1.60e-03 | 46 | 26 | 2 | int:TMEM230 | |
| Interaction | TMA7 interactions | 1.60e-03 | 46 | 26 | 2 | int:TMA7 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q23 | 2.17e-03 | 117 | 27 | 2 | chr5q23 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 2.86e-06 | 4 | 13 | 2 | 1096 | |
| GeneFamily | Laminin subunits | 3.14e-05 | 12 | 13 | 2 | 626 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.19e-10 | 196 | 27 | 7 | M3008 | |
| Coexpression | NABA_MATRISOME | LAMA2 LAMB2 LTBP3 FBN1 FBN2 ADAMTS14 MEGF6 EGFL8 SSPOP FBN3 MEGF10 | 2.30e-09 | 1026 | 27 | 11 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 9.62e-09 | 275 | 27 | 7 | M5884 | |
| Coexpression | NABA_MATRISOME | LAMA2 LAMB2 LTBP3 FBN1 FBN2 ADAMTS14 MEGF6 EGFL8 SSPOP MEGF10 | 3.14e-08 | 1008 | 27 | 10 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.61e-08 | 191 | 27 | 6 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 2.79e-07 | 270 | 27 | 6 | MM17057 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 7.23e-06 | 268 | 27 | 5 | M45796 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 2.92e-05 | 174 | 27 | 4 | M45676 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | 3.32e-05 | 368 | 27 | 5 | M16431 | |
| Coexpression | DESCARTES_FETAL_HEART_SCHWANN_CELLS | 4.47e-05 | 67 | 27 | 3 | M40194 | |
| Coexpression | FRASOR_RESPONSE_TO_ESTRADIOL_DN | 7.04e-05 | 78 | 27 | 3 | M3002 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 9.87e-05 | 238 | 27 | 4 | M12004 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 2.85e-04 | 125 | 27 | 3 | M1320 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 3.55e-04 | 610 | 27 | 5 | M3854 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 3.73e-04 | 337 | 27 | 4 | M13206 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_CORTICAL_PLATE | 4.66e-04 | 31 | 27 | 2 | MM439 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 4.74e-04 | 650 | 27 | 5 | MM1042 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOPC | 5.09e-04 | 366 | 27 | 4 | M39052 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 5.45e-04 | 156 | 27 | 3 | MM550 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 5.62e-04 | 34 | 27 | 2 | M14043 | |
| Coexpression | GYORFFY_MITOXANTRONE_RESISTANCE | 5.95e-04 | 35 | 27 | 2 | M1988 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 5.95e-04 | 35 | 27 | 2 | M11788 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 6.16e-04 | 385 | 27 | 4 | M39264 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.30e-04 | 36 | 27 | 2 | MM1212 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | 6.40e-04 | 389 | 27 | 4 | M6520 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | 6.77e-04 | 703 | 27 | 5 | M39070 | |
| Coexpression | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP | 7.40e-04 | 39 | 27 | 2 | M13339 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 7.58e-04 | 721 | 27 | 5 | M1999 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 7.78e-04 | 40 | 27 | 2 | M5887 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN | 8.12e-04 | 179 | 27 | 3 | M8519 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 8.12e-04 | 179 | 27 | 3 | M39308 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_STROMAL_CELLS | 8.17e-04 | 41 | 27 | 2 | M40216 | |
| Coexpression | ATF2_S_UP.V1_DN | 9.21e-04 | 187 | 27 | 3 | M2681 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP | 9.50e-04 | 189 | 27 | 3 | M4199 | |
| Coexpression | HALMOS_CEBPA_TARGETS_DN | 9.84e-04 | 45 | 27 | 2 | M8604 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.00e-03 | 767 | 27 | 5 | M39209 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP | 1.06e-03 | 196 | 27 | 3 | M8161 | |
| Coexpression | GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP | 1.06e-03 | 196 | 27 | 3 | M7238 | |
| Coexpression | GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN | 1.09e-03 | 198 | 27 | 3 | M7267 | |
| Coexpression | GSE3982_BASOPHIL_VS_NKCELL_DN | 1.09e-03 | 198 | 27 | 3 | M5563 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN | 1.10e-03 | 199 | 27 | 3 | M9941 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN | 1.12e-03 | 200 | 27 | 3 | M6258 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP | 1.12e-03 | 200 | 27 | 3 | M4576 | |
| Coexpression | GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP | 1.12e-03 | 200 | 27 | 3 | M7018 | |
| Coexpression | GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP | 1.12e-03 | 200 | 27 | 3 | M7506 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.12e-03 | 200 | 27 | 3 | M5930 | |
| Coexpression | GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.12e-03 | 200 | 27 | 3 | M9553 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.21e-03 | 50 | 27 | 2 | M1259 | |
| Coexpression | TSUNODA_CISPLATIN_RESISTANCE_DN | 1.21e-03 | 50 | 27 | 2 | M5014 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 1.21e-03 | 50 | 27 | 2 | MM403 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 1.25e-03 | 208 | 27 | 3 | M39139 | |
| Coexpression | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER | 1.31e-03 | 52 | 27 | 2 | M19766 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.31e-03 | 52 | 27 | 2 | MM1118 | |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN | 1.36e-03 | 53 | 27 | 2 | M8077 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.66e-06 | 310 | 26 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | placenta | 3.29e-06 | 349 | 26 | 6 | placenta | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.85e-05 | 146 | 26 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | 4.64e-05 | 1148 | 26 | 8 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.82e-05 | 336 | 26 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_500 | 6.46e-05 | 64 | 26 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k4 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 6.77e-05 | 65 | 26 | 3 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 6.77e-05 | 361 | 26 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.11e-04 | 207 | 26 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.24e-04 | 466 | 26 | 5 | GSM777050_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 2.72e-04 | 768 | 26 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 2.81e-04 | 773 | 26 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.86e-04 | 265 | 26 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 2.89e-04 | 777 | 26 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.92e-04 | 288 | 26 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.16e-04 | 120 | 26 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 4.37e-04 | 122 | 26 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 4.68e-04 | 850 | 26 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | 4.79e-04 | 1208 | 26 | 7 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | 5.29e-04 | 1228 | 26 | 7 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_200 | 6.56e-04 | 31 | 26 | 2 | gudmap_developingKidney_e11.5_ureteric bud_200_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.07e-04 | 337 | 26 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 7.67e-04 | 148 | 26 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.49e-04 | 354 | 26 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 8.67e-04 | 356 | 26 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 8.93e-04 | 156 | 26 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.61e-04 | 160 | 26 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.05e-03 | 165 | 26 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.07e-03 | 166 | 26 | 3 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 1.19e-03 | 388 | 26 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-09 | 193 | 27 | 6 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-09 | 193 | 27 | 6 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-09 | 197 | 27 | 6 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-09 | 198 | 27 | 6 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.32e-08 | 169 | 27 | 5 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.70e-08 | 182 | 27 | 5 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-08 | 183 | 27 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.35e-08 | 185 | 27 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-08 | 185 | 27 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-08 | 185 | 27 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.58e-08 | 186 | 27 | 5 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.81e-08 | 187 | 27 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-08 | 187 | 27 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.05e-08 | 188 | 27 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | wk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.05e-08 | 188 | 27 | 5 | 3f3a744b2615bf72f6119f26087099110c0d21fc | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-07 | 192 | 27 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.00e-07 | 192 | 27 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-07 | 192 | 27 | 5 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-07 | 193 | 27 | 5 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-07 | 193 | 27 | 5 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-07 | 194 | 27 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-07 | 197 | 27 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-07 | 197 | 27 | 5 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-07 | 199 | 27 | 5 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-07 | 199 | 27 | 5 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-07 | 200 | 27 | 5 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-07 | 200 | 27 | 5 | 363a8cebf2ace820661bcb87c7941f6671f8e5f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-07 | 200 | 27 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.12e-06 | 153 | 27 | 4 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 169 | 27 | 4 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-06 | 169 | 27 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-06 | 171 | 27 | 4 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.30e-06 | 171 | 27 | 4 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-06 | 171 | 27 | 4 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.38e-06 | 172 | 27 | 4 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-06 | 173 | 27 | 4 | 922356a5b4c84607318ac24d7caa2e235b72b066 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-06 | 175 | 27 | 4 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.62e-06 | 175 | 27 | 4 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 176 | 27 | 4 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-06 | 176 | 27 | 4 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 176 | 27 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 3.87e-06 | 178 | 27 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | wk_08-11-Epithelial-PNS-Late_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.87e-06 | 178 | 27 | 4 | a7301c0bba03d10feacc02e3f929d9a9235fd25b | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-06 | 181 | 27 | 4 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-06 | 181 | 27 | 4 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-06 | 181 | 27 | 4 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 182 | 27 | 4 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 182 | 27 | 4 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 182 | 27 | 4 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.23e-06 | 182 | 27 | 4 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 184 | 27 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 184 | 27 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 184 | 27 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.41e-06 | 184 | 27 | 4 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | wk_08-11-Epithelial-PNS-COL20A1+_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.51e-06 | 185 | 27 | 4 | abec2a49fe0f0fa4cba49347207a1ee317333657 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.51e-06 | 185 | 27 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 185 | 27 | 4 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-06 | 185 | 27 | 4 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-06 | 186 | 27 | 4 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.61e-06 | 186 | 27 | 4 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-06 | 186 | 27 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.61e-06 | 186 | 27 | 4 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 187 | 27 | 4 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 187 | 27 | 4 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 187 | 27 | 4 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.71e-06 | 187 | 27 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 188 | 27 | 4 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 188 | 27 | 4 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.81e-06 | 188 | 27 | 4 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 188 | 27 | 4 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | Endothelial-B|World / lung cells shred on cell class, cell subclass, sample id | 4.81e-06 | 188 | 27 | 4 | 5959a88728812a5f4cbfa54eddc7a73ccbaa2f68 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 4.91e-06 | 189 | 27 | 4 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 189 | 27 | 4 | 6b3b42d758b63a0df62310c34fa3bde421c1afd7 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 189 | 27 | 4 | 344b23d3c47d0665dda1cd4856a5e72f1c28cfb3 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.01e-06 | 190 | 27 | 4 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.12e-06 | 191 | 27 | 4 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.12e-06 | 191 | 27 | 4 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.12e-06 | 191 | 27 | 4 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 191 | 27 | 4 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 192 | 27 | 4 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-06 | 192 | 27 | 4 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 192 | 27 | 4 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 193 | 27 | 4 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.33e-06 | 193 | 27 | 4 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.33e-06 | 193 | 27 | 4 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.33e-06 | 193 | 27 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 193 | 27 | 4 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.33e-06 | 193 | 27 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.44e-06 | 194 | 27 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 5.44e-06 | 194 | 27 | 4 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.44e-06 | 194 | 27 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-06 | 195 | 27 | 4 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-06 | 195 | 27 | 4 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-06 | 195 | 27 | 4 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-06 | 195 | 27 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-06 | 195 | 27 | 4 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.67e-06 | 196 | 27 | 4 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 196 | 27 | 4 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.67e-06 | 196 | 27 | 4 | e6adcfe1a00d4910e0b92848f8a80224e0d6db12 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.67e-06 | 196 | 27 | 4 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| Computational | Adhesion molecules. | 3.46e-05 | 141 | 15 | 4 | MODULE_122 | |
| Computational | Metal / Ca ion binding. | 7.56e-04 | 133 | 15 | 3 | MODULE_324 | |
| Computational | Developmental processes. | 9.42e-04 | 333 | 15 | 4 | MODULE_220 | |
| Computational | RTK signaling. | 1.82e-03 | 46 | 15 | 2 | MODULE_259 | |
| Computational | Genes in the cancer module 85. | 2.23e-03 | 51 | 15 | 2 | MODULE_85 | |
| Computational | Bone remodeling. | 2.49e-03 | 54 | 15 | 2 | MODULE_234 | |
| Computational | Genes in the cancer module 199. | 2.78e-03 | 57 | 15 | 2 | MODULE_199 | |
| Computational | Placenta genes. | 3.17e-03 | 463 | 15 | 4 | MODULE_38 | |
| Computational | ECM and collagens. | 3.42e-03 | 225 | 15 | 3 | MODULE_47 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 2.70e-06 | 83 | 27 | 4 | CID011968896 | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 3.35e-06 | 199 | 27 | 5 | 6818_UP | |
| Drug | 2-acetamidoethanethiol | 4.06e-06 | 3 | 27 | 2 | ctd:C023704 | |
| Drug | ZD-6 | 2.03e-05 | 6 | 27 | 2 | CID010062753 | |
| Drug | funiferine N-oxide | 2.64e-05 | 49 | 27 | 3 | CID000191631 | |
| Drug | desmosine | 3.35e-05 | 53 | 27 | 3 | CID000025435 | |
| Drug | Folfox protocol | 3.78e-05 | 8 | 27 | 2 | ctd:C410216 | |
| Drug | PC9 | 4.63e-05 | 59 | 27 | 3 | CID016040245 | |
| Drug | LG 5 | 4.86e-05 | 60 | 27 | 3 | CID011840957 | |
| Drug | 6-(methylamino)pyrido(3,4-d)pyrimidine | 6.06e-05 | 10 | 27 | 2 | ctd:C107875 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 6.53e-05 | 186 | 27 | 4 | 4463_UP | |
| Drug | BM165 | 7.40e-05 | 11 | 27 | 2 | CID003352881 | |
| Drug | AC1L1G72 | 7.40e-05 | 11 | 27 | 2 | CID000003553 | |
| Drug | BE-23372M | 7.40e-05 | 11 | 27 | 2 | CID005311105 | |
| Drug | 1xqc | 7.40e-05 | 11 | 27 | 2 | CID005287617 | |
| Drug | 2-amino-5-methylpyridine | 1.03e-04 | 77 | 27 | 3 | CID000015348 | |
| Drug | CMF regimen | 1.05e-04 | 13 | 27 | 2 | ctd:C034456 | |
| Drug | NSC 714187 | 1.38e-04 | 85 | 27 | 3 | CID005288693 | |
| Drug | NVP-TAE684 | 1.41e-04 | 15 | 27 | 2 | ctd:C516714 | |
| Drug | 4-anilinoquinazoline | 1.61e-04 | 16 | 27 | 2 | CID000324081 | |
| Drug | Rgd Peptide | 1.72e-04 | 239 | 27 | 4 | CID000104802 | |
| Drug | germanium monoxide | 1.74e-04 | 92 | 27 | 3 | CID006327639 | |
| Drug | quinocetone | 1.98e-04 | 248 | 27 | 4 | ctd:C502851 | |
| Drug | NCI60_002052 | 2.54e-04 | 20 | 27 | 2 | CID006801032 | |
| Drug | ZD4190 | 2.54e-04 | 20 | 27 | 2 | CID005329032 | |
| Drug | NSC226080 | 2.57e-04 | 782 | 27 | 6 | CID000005040 | |
| Drug | Prestwick_517 | 2.64e-04 | 106 | 27 | 3 | CID000003804 | |
| Drug | TAAD | 2.80e-04 | 21 | 27 | 2 | CID000133445 | |
| Drug | HgBr2 | 3.08e-04 | 22 | 27 | 2 | CID000024612 | |
| Drug | AC1L1CT9 | 3.37e-04 | 23 | 27 | 2 | CID000002054 | |
| Drug | PHA665752 | 3.37e-04 | 23 | 27 | 2 | CID010461815 | |
| Disease | connective tissue disease (implicated_via_orthology) | 6.83e-10 | 3 | 27 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 4.83e-06 | 4 | 27 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Geleophysic dysplasia | 8.05e-06 | 5 | 27 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 8.05e-06 | 5 | 27 | 2 | C0265287 | |
| Disease | Head and Neck Carcinoma | 3.61e-05 | 10 | 27 | 2 | C3887461 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.75e-05 | 71 | 27 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 4.41e-05 | 11 | 27 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 4.41e-05 | 11 | 27 | 2 | C0153452 | |
| Disease | median neuropathy (biomarker_via_orthology) | 7.29e-05 | 14 | 27 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | Benign neoplasm of stomach | 1.09e-04 | 17 | 27 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.09e-04 | 17 | 27 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.09e-04 | 17 | 27 | 2 | C0154060 | |
| Disease | Child Behaviour Checklist assessment | 1.22e-04 | 18 | 27 | 2 | EFO_0005661 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.37e-04 | 19 | 27 | 2 | DOID:2876 (is_marker_for) | |
| Disease | cortical surface area measurement | 1.60e-04 | 1345 | 27 | 7 | EFO_0010736 | |
| Disease | Stomach Carcinoma | 1.68e-04 | 21 | 27 | 2 | C0699791 | |
| Disease | sleep quality | 1.70e-04 | 118 | 27 | 3 | EFO_0005272 | |
| Disease | Nasopharyngeal carcinoma | 1.84e-04 | 22 | 27 | 2 | C2931822 | |
| Disease | stomach carcinoma (is_marker_for) | 2.20e-04 | 24 | 27 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Periodontal Pocket | 2.39e-04 | 25 | 27 | 2 | EFO_1001393 | |
| Disease | Bladder Neoplasm | 2.81e-04 | 140 | 27 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.87e-04 | 141 | 27 | 3 | C0005684 | |
| Disease | sleep duration | 3.13e-04 | 362 | 27 | 4 | EFO_0005271 | |
| Disease | Malignant neoplasm of breast | 3.52e-04 | 1074 | 27 | 6 | C0006142 | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.93e-04 | 32 | 27 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | Head and Neck Neoplasms | 4.18e-04 | 33 | 27 | 2 | C0018671 | |
| Disease | refractive error, self reported educational attainment | 4.44e-04 | 34 | 27 | 2 | EFO_0004784, MONDO_0004892 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | 5.26e-04 | 37 | 27 | 2 | EFO_0004276, EFO_0004775, EFO_0006997 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 5.85e-04 | 39 | 27 | 2 | DOID:0060074 (is_marker_for) | |
| Disease | Malignant Head and Neck Neoplasm | 7.45e-04 | 44 | 27 | 2 | C0278996 | |
| Disease | myopathy (implicated_via_orthology) | 8.86e-04 | 48 | 27 | 2 | DOID:423 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CHQLCARGHCWGPGP | 511 | P04626 | |
| CHEVCKGRCWGPGSE | 186 | P21860 | |
| ECAPGWGGKHCHVDV | 131 | Q99944 | |
| CRCLPGWVGDGFECH | 1306 | Q75N90 | |
| GTECAPGKWCFKGHC | 526 | Q8WXS8 | |
| GDHWGPHCTSRCQCK | 141 | Q96KG7 | |
| ICPLGWTGHHCLEGC | 681 | Q5VY43 | |
| LHWGDPGLQCHACDC | 1131 | P55268 | |
| IHGERKEFVCHWGGC | 261 | P08151 | |
| GATGRKCDGCKHWHA | 1551 | P24043 | |
| GGRGQPKDEVDWCCH | 51 | Q9BZM2 | |
| GICTWGGQHCGCPAK | 21 | Q5T319 | |
| VKGVPCCWHCEACDG | 531 | O15303 | |
| SECCCDGGRGWGPHC | 2361 | P35555 | |
| ECCCSLGAGWGDHCE | 941 | Q9NS15 | |
| CCDGGRGWGHQCELC | 2411 | P35556 | |
| DTGHWGPDCSHPCNC | 861 | O75095 | |
| CQEGQWHCGGDGGHC | 1356 | A2VEC9 | |
| WHCGGDGGHCEELVP | 1361 | A2VEC9 | |
| GWHGPGCQRPCKCEH | 396 | Q9UK23 | |
| GHCVCRHGWKGPECD | 576 | Q9UKZ4 | |
| HGICVKGECHCSTGW | 636 | Q9UKZ4 | |
| HGVCIGGACRCEEGW | 746 | Q9NT68 | |
| VCPAGYRGDGWHCEC | 136 | P07911 | |
| KECPGCLHGGVCHDH | 226 | P35590 | |
| SGCVCPSGWHGVHCE | 331 | P35590 | |
| GVCVRGECHCSVGWG | 671 | Q6N022 | |
| HCVCQPGWRGAGCDV | 761 | Q9P273 | |
| FDHHCPWVGNCVGKR | 191 | Q8IZN3 | |
| CGGWEDGKAHGHGVC | 16 | Q8WXH2 |